Source: International Congress 2019 – Diagnostic issues in obstructive sleep apnoea
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
M. Sova (Olomouc, Czech Republic), S. Genzor (Olomouc, Czech Republic), E. Sovova (Olomouc, Czech Republic), A. Ghazal Asswad (Olomouc, Czech Republic). Adiponectin and epicardial fat in patients with obstructive sleep apnoea. 811

Member's Comments

No comment yet.

Related content which might interest you: Leptin in obstructive sleep apnea Source: Eur Respir J 2001; 18: Suppl. 33, 333s Year: 2001 Visceral fat in non-to-moderate and severe obstructive sleep apnoea Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I Year: 2012 Leptin and ghrelin levels in patients with obstructive sleep apnea syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 332s Year: 2004 Insulin resistance in obstructive sleep apnea patients Source: Annual Congress 2010 - Pulmonary circulation III Year: 2010 Can leptin be used to treat obstructive sleep apnoea? Source: International Congress 2019 – New horizons for pharmacotherapy of sleep-disordered breathing: from bench to bedside Year: 2019 Metabolic syndrome in obstructive sleep apnoea patients Source: Annual Congress 2007 - Sleep apnoea Year: 2007 Determinants of hypercapnia in obese obstructive sleep apnea (OSA) patients Source: Eur Respir J 2004; 24: Suppl. 48, 447s Year: 2004 Cortisol metabolism in obstructive sleep apnea (OSA) Source: Eur Respir J 2002; 20: Suppl. 38, 215s Year: 2002 Investigation on serum adiponectin levels in patients with obstructive sleep apnea hypopnea syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 445s Year: 2004 The inflammation and insulin resistance in obstructive sleep apnea Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I Year: 2012 Serum leptin levels in obstructive sleep apnoea patients Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea Year: 2007 The influence of obesity in patients with obstructive sleep apnea syndrome Source: Eur Respir J 2002; 20: Suppl. 38, 295s Year: 2002 Serum fibrinogen in patients with obstructive sleep apnea Source: Virtual Congress 2020 – Consequences for obstructive sleep apnoea and potential modalities for early identification Year: 2020 Roles of periostin in patients with severe obstructive sleep apnea Source: International Congress 2017 – New pathophysiological insights: intermittent hypoxia, cardiopulmonary function and biomarkers Year: 2017 Cardiac echo indices in patients with obstructive sleep apnea and COPD Source: Annual Congress 2009 - Control of breathing and respiratory disorders during sleep Year: 2009 Markers of liver dysfunction in patients with obstructive sleep apnea Source: Annual Congress 2011 - Obstructive sleep apnoea: inflammation and metabolism Year: 2011 Leptin and ghrelin levels in patients with obstructive sleep apnoea: effect of CPAP treatment Source: Eur Respir J 2003; 22: 251-257 Year: 2003 Influence of body weight on plasma NT-proBNP in obstructive sleep apnoea (OSA) patients Source: Annual Congress 2007 - Cardiovascular and respiratory control in obstructive sleep apnoea Year: 2007 Glucose metabolism abnormalities in obstructive sleep apnoea (OSA) patients Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I Year: 2012 Metabolic disturbances in patients with obstructive sleep apnoea syndrome Source: Eur Respir Rev 2007; 16: 196-202 Year: 2007